复发或转移性乳腺癌3种代表化疗方案的成本-效果分析  

Cost-effectiveness analysis of cancer with 3 chemical therapy schemes

作　　者：郭红[1] 单文治[1] 张秀明[1] 蔡丽娟[1] 

机构地区：[1]解放军总医院药品保障中心,北京100853

出　　处：《中国药物应用与监测》2007年第2期25-28,共4页Chinese Journal of Drug Application and Monitoring

摘　　要：目的:评价复发或转移性乳腺癌3种代表化疗方案的成本-效果。方法:对52例复发或转移性乳腺癌化疗患者分别采用3种给药方案治疗,方案A为AT方案,方案B为XT方案,方案C为GT方案,治疗2个周期评价疗效。运用药物经济学方法进行成本-效果分析。结果:3种化疗方案成本分别为32700.88元、28321.88元、45861.68元,显效率分别为63.15%、62.50%、64.71%,成本-效果比分别为517.83、453.15、708.73。不良反应为不同程度的骨髓抑制、恶心呕吐、脱发等、手足综合征、血小板变化等,经对症治疗病人均耐受。结论:方案B为最优方案。Objective：To conduct cost-effectiveness analysis with 3 chemical therapy schemes on soaked mammary cancer after surgery.Methods：52 Soaked mammary cancer cases were treated with 3 schemes respectively, and scheme A is AT, scheme B is XT , scheme C is GT.The curative effects were observed and analyzed by cost-effectiveness method.Results：They cost 32700.88, 28321.88,45861.68 yuan respectively, and the effective rates were 63.15% ,62.50% ,64.71%.The cost-effectiveness ratios were 517.83,453.15,708.73 respectively.Conclusion：Scheme B is the best.

关 键 词：复发或转移性乳腺癌 化疗方案 成本-效果分析 

分 类 号：R737.9[医药卫生—肿瘤]